What the ATTAIN-MAINTAIN Trial Means for GLP-1 Patients
Dr. Renée AllenPublished on: 13/05/2026
New clinical data confirms oral GLP-1 therapy can sustain weight loss and cardiometabolic health after stopping injectables — and what this means within Eterna's precision framework.
Women's Health and WellnessWomen's Nutrition and Medical Weight ManagementPrecision MedicineRegenerative MedicineLongevity Medicine